Ronald Renaud

Ronald Renaud

Chief Executive Officer presso CEREVEL THERAPEUTICS HOLDINGS, INC.

Patrimonio netto: 10 M $ in data 29/02/2024

55 anni
Health Technology
Finance
Consumer Services

Profilo

Ronald C.
Renaud
is a businessperson who has been at the helm of 6 different companies and presently occupies the position of Independent Chairman at Axial Therapeutics, Inc., President.
Chief Executive Officer & Director at Cerevel Therapeutics Holdings, Inc., Advisor at Atlas Venture Advisors, Inc. and Senior Advisor at Bain Capital Life Sciences LP.
He is also on the board of St. Anselm College, Jnana Therapeutics, Inc. and Upstream Bio, Inc. and Member-Overseers Board at Newton-Wellesley Hospital Corp.
In his past career he held the position of Chairperson of the Board at Atara Biotherapeutics, Inc., Chairman for Ikena Oncology, Inc., Managing Director at Soundview Capital Management Corp., Partner at Bain Capital Holdings LP, Chairman & Chief Executive Officer of Translate Bio, Inc., President, CEO, CFO & Director at Idenix Pharmaceuticals LLC, Chief Financial Officer, Treasurer & Senior VP for Keryx Biopharmaceuticals, Inc., Managing Director at Bear, Stearns & Co., Inc., Managing Director at Charles Schwab & Co., Inc., Managing Director at Bear, Stearns & Co., Inc., Analyst at JPMorgan Securities LLC and Research Analyst at Schwab SoundView Capital Markets.
Ronald C.
Renaud
received an undergraduate degree from St. Anselm College and an MBA from USC Marshall School of Business.

Partecipazioni note in società pubbliche

SocietàDataNumero di azioniValorizzazioneData di valutazione
19/01/2024 244 309 ( 0.13% ) 10 M $ 29/02/2024

Posizioni attive di Ronald Renaud

SocietàPosizioneInizio
CEREVEL THERAPEUTICS HOLDINGS, INC. Chief Executive Officer 12/06/2023
Chairman -
Director/Board Member -
Director/Board Member -
Consultant / Advisor -
Corporate Officer/Principal -
St. Anselm College Director/Board Member -
Consultant / Advisor 01/06/2023
Tutte le posizioni attive di Ronald Renaud

Precedenti posizioni note di Ronald Renaud

SocietàPosizioneFine
Private Equity Investor 01/06/2023
░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ ░░░░░░░░ ░░░░░░░░░░
░░░░░ ░░░░░░░░░ ░░░░ ░░░░░░░░ ░░░░░░░░░░
░░░░░░░░░ ░░░░ ░░░░ ░░░░░ ░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
Vedi nel dettaglio l'esperienza di Ronald Renaud

Formazione di Ronald Renaud

St. Anselm College Undergraduate Degree
USC Marshall School of Business Masters Business Admin

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Ronald Renaud

Relazioni

100 +

Relazioni di 1° grado

24

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa6
CHIMERIX, INC.

Health Technology

PTC THERAPEUTICS, INC.

Health Technology

AKEBIA THERAPEUTICS, INC.

Health Technology

IKENA ONCOLOGY, INC.

Health Technology

CEREVEL THERAPEUTICS HOLDINGS, INC.

Health Technology

ATARA BIOTHERAPEUTICS, INC.

Health Technology

Aziende private16

Finance

Health Technology

Health Technology

Finance

Finance

Health Technology

Schwab SoundView Capital Markets

Finance

Finance

Health Services

American Liver Foundation of Northern California

Finance

Finance

Health Technology

Miscellaneous

Health Technology

Commercial Services

Vedi le connessioni aziendali
  1. Borsa
  2. Insiders
  3. Ronald Renaud